New assay may help predict which pancreatic lesions may become cancerous

A report in The Journal of Molecular Diagnostics, describes a new simple molecular test to detect chromosomal abnormalities — biomarkers known as telomere fusions — in pancreatic tumor specimens and pancreatic cyst fluids. This assay may help predict the presence of high-grade or invasive pancreatic cancers requiring surgical intervention. …read more

Source: EurekAlert

(Visited 2 times, 1 visits today)

Popular Posts